Stay updated on Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-17T03:11:54.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed the prior Revision: v3.4.0 notice along with the old government funding status message. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-09T22:48:03.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, stating that information may not be up to date and directing users to cc.nih.gov and opm.gov for status; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-02T19:04:37.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added a glossary toggle and several new data fields (Results First Posted, Certification/Extension First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0). Removed the estimated variants of these fields and the older revision (v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-26T19:40:28.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a minor backend/frontend version update with no observable changes to the Study Details page.
    Difference
    0.0%
    Check dated 2026-01-19T13:48:50.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    - The Locations section was expanded to include numerous new study sites across the United States and internationally (including Argentina, Australia, Canada, and various European and Asian countries). This broadens access by showing more sites where the COSMIC-312 trial is conducted.
    Difference
    3%
    Check dated 2025-12-21T21:24:58.000Z thumbnail image

Stay in the know with updates to Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.